Market Cap 27.73M
Revenue (ttm) 0.00
Net Income (ttm) -62.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 64,100
Avg Vol 150,874
Day's Range N/A - N/A
Shares Out 23.31M
Stochastic %K 33%
Beta 1.14
Analysts Sell
Price Target $10.00

Company Profile

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 802 1989
Address:
12407 N. Mopac Expy., Suite 250 #390, Austin, United States
Raxothus
Raxothus Sep. 25 at 7:27 PM
EOD CONTINUATION FOLLOW-UP – 09/22/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $VEEE – Closed 2.72, now 2.80 (+2.9%). Holding gains, may continue. ✅ $BNZI – Closed 2.78, now 3.02 (+8.6%). Showing continuation potential. ⚠️ $RNTX – Sideways movement. Neutral. ⚠️ $DBGI – Sideways movement. Neutral. ⚠️ $JAGX – Sideways movement. Neutral. Recap: 5 total → 2 winners, 0 fails, 3 neutral → 40% accuracy Leaders: $BNZI (+8.6%) and $VEEE (+2.9%) both showed continuation strength. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
highnihilism
highnihilism Sep. 25 at 12:00 PM
Volume (Relative to 90-Day Average) → $RNTX Rein Therapeutics × 10.2 $KUKE Kuke Music Hldg × 5.4 $RNXT Renovorx × 1.8 $NVX Novonix × 3 $IVDA Iveda Solutions × 16.1
0 · Reply
Raxothus
Raxothus Sep. 24 at 7:35 PM
EOD CONTINUATION WATCHLIST – 09/22/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $VEEE – 42.0x volume, 4.4% VWAP stretch, micro float (2.0M) 1.5% open-to-current with 4.9% late push, RSI 49.9. Extreme volume, watching breakout > 2.76 for continuation. $BNZI – 4.4x volume, 2.5% VWAP stretch, micro float (3.2M) 7.4% open-to-current with 4.1% late push, RSI 48.8. Watching breakout > 2.85 for continuation. $RNTX – 2.8x volume, 0.5% VWAP stretch, small float (19.8M) 2.4% open-to-current with –1.9% late pull, RSI 39.7. Needs breakout > 1.21 for continuation. $DBGI – 5.3x volume, 7.4% VWAP stretch, micro float (4.5M) 36.8% open-to-current with 4.7% late push, RSI 48.0. Strong mover, watching breakout > 6.92 for continuation. $JAGX – 16.1x volume, 8.9% VWAP stretch, micro float (1.5M) 8.9% open-to-current with 8.4% late push, RSI 84.5. Low-float leader, watching breakout > 2.25 for continuation. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups #PowerHourWatch
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:02 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $JYD $RNTX $ELPW $WKSP $TOPP all worth watching
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 8:04 AM
$RNTX Brilliant piece that captures RNTX's situation perfectly. So if you want to update your understanding of RNTX or get to know RNTX better, this is essential reading. https://beyondspx.com/quote/RNTX/analysis/rein-therapeutics-a-high-stakes-pivot-in-fibrosis-treatment-amidst-clinical-and-capital-hurdles-nasdaq-rntx
0 · Reply
JL_TradeZ
JL_TradeZ Sep. 1 at 2:44 PM
Final Watchlist Tues Sept 2nd $KTTA – 7.3M float, sitting right at 0.85 breakout. PAS-004 trial is moving clean with no issues and they’re presenting at H.C. Wainwright next week. Friday’s volume was almost 2x average which shows buyers are positioning $KAPA – Around 14M float with solid insider ownership. September is stacked with the H.C. Wainwright conference and Phase 2 efficacy data. Chart is tight under 1.50 and every catalyst this year has sparked big moves $RNTX – Got UK approval to run a Phase 2 trial which gave it a spark. Float is 22M and Friday saw 13x average volume. Momentum is alive but dilution risk is still on the table, so this one’s only good for short-term trades $CLRB – Just 3.18M float and has FDA Breakthrough designation plus 83% ORR data backing it. Story is strong and chart is coiling under 5 with a squeeze forming. Needs volume but if it gets it this can rip $ONDS – Defense and drone play with Palantir, FAA waiver, and defense orders all stacked up. Big float at 252M but the tape has been strong and volume rotation is there. Break over 6 can open the door to 6.50–7
3 · Reply
ahTony
ahTony Aug. 29 at 11:00 PM
$RNTX whats going on here?
0 · Reply
dbr_island
dbr_island Aug. 29 at 10:52 PM
$RNTX there it goes AH SRXH is my next BIG runner 🚨🚨🚨 I want $1 at MINIMUM 🎯✅ WATCH AND LEARN LIKE👇
1 · Reply
lrak02
lrak02 Aug. 29 at 10:51 PM
$RNTX what
0 · Reply
rapture_iscoming
rapture_iscoming Aug. 29 at 7:24 PM
$RNTX last chance to enter before $10
1 · Reply
Latest News on RNTX
US FDA puts on hold Rein Therapeutics' lung disease drug trial

Jun 12, 2025, 5:18 PM EDT - 4 months ago

US FDA puts on hold Rein Therapeutics' lung disease drug trial


Raxothus
Raxothus Sep. 25 at 7:27 PM
EOD CONTINUATION FOLLOW-UP – 09/22/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $VEEE – Closed 2.72, now 2.80 (+2.9%). Holding gains, may continue. ✅ $BNZI – Closed 2.78, now 3.02 (+8.6%). Showing continuation potential. ⚠️ $RNTX – Sideways movement. Neutral. ⚠️ $DBGI – Sideways movement. Neutral. ⚠️ $JAGX – Sideways movement. Neutral. Recap: 5 total → 2 winners, 0 fails, 3 neutral → 40% accuracy Leaders: $BNZI (+8.6%) and $VEEE (+2.9%) both showed continuation strength. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
highnihilism
highnihilism Sep. 25 at 12:00 PM
Volume (Relative to 90-Day Average) → $RNTX Rein Therapeutics × 10.2 $KUKE Kuke Music Hldg × 5.4 $RNXT Renovorx × 1.8 $NVX Novonix × 3 $IVDA Iveda Solutions × 16.1
0 · Reply
Raxothus
Raxothus Sep. 24 at 7:35 PM
EOD CONTINUATION WATCHLIST – 09/22/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $VEEE – 42.0x volume, 4.4% VWAP stretch, micro float (2.0M) 1.5% open-to-current with 4.9% late push, RSI 49.9. Extreme volume, watching breakout > 2.76 for continuation. $BNZI – 4.4x volume, 2.5% VWAP stretch, micro float (3.2M) 7.4% open-to-current with 4.1% late push, RSI 48.8. Watching breakout > 2.85 for continuation. $RNTX – 2.8x volume, 0.5% VWAP stretch, small float (19.8M) 2.4% open-to-current with –1.9% late pull, RSI 39.7. Needs breakout > 1.21 for continuation. $DBGI – 5.3x volume, 7.4% VWAP stretch, micro float (4.5M) 36.8% open-to-current with 4.7% late push, RSI 48.0. Strong mover, watching breakout > 6.92 for continuation. $JAGX – 16.1x volume, 8.9% VWAP stretch, micro float (1.5M) 8.9% open-to-current with 8.4% late push, RSI 84.5. Low-float leader, watching breakout > 2.25 for continuation. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups #PowerHourWatch
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:02 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $JYD $RNTX $ELPW $WKSP $TOPP all worth watching
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 8:04 AM
$RNTX Brilliant piece that captures RNTX's situation perfectly. So if you want to update your understanding of RNTX or get to know RNTX better, this is essential reading. https://beyondspx.com/quote/RNTX/analysis/rein-therapeutics-a-high-stakes-pivot-in-fibrosis-treatment-amidst-clinical-and-capital-hurdles-nasdaq-rntx
0 · Reply
JL_TradeZ
JL_TradeZ Sep. 1 at 2:44 PM
Final Watchlist Tues Sept 2nd $KTTA – 7.3M float, sitting right at 0.85 breakout. PAS-004 trial is moving clean with no issues and they’re presenting at H.C. Wainwright next week. Friday’s volume was almost 2x average which shows buyers are positioning $KAPA – Around 14M float with solid insider ownership. September is stacked with the H.C. Wainwright conference and Phase 2 efficacy data. Chart is tight under 1.50 and every catalyst this year has sparked big moves $RNTX – Got UK approval to run a Phase 2 trial which gave it a spark. Float is 22M and Friday saw 13x average volume. Momentum is alive but dilution risk is still on the table, so this one’s only good for short-term trades $CLRB – Just 3.18M float and has FDA Breakthrough designation plus 83% ORR data backing it. Story is strong and chart is coiling under 5 with a squeeze forming. Needs volume but if it gets it this can rip $ONDS – Defense and drone play with Palantir, FAA waiver, and defense orders all stacked up. Big float at 252M but the tape has been strong and volume rotation is there. Break over 6 can open the door to 6.50–7
3 · Reply
ahTony
ahTony Aug. 29 at 11:00 PM
$RNTX whats going on here?
0 · Reply
dbr_island
dbr_island Aug. 29 at 10:52 PM
$RNTX there it goes AH SRXH is my next BIG runner 🚨🚨🚨 I want $1 at MINIMUM 🎯✅ WATCH AND LEARN LIKE👇
1 · Reply
lrak02
lrak02 Aug. 29 at 10:51 PM
$RNTX what
0 · Reply
rapture_iscoming
rapture_iscoming Aug. 29 at 7:24 PM
$RNTX last chance to enter before $10
1 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 2:18 PM
Brookline Capital has updated their rating for Rein Therapeutics ( $RNTX ) to Hold.
0 · Reply
jcooptechit
jcooptechit Aug. 8 at 4:53 PM
$RNTX is revolutionizing cancer care! 🔹 FDA-cleared RenovoCath targets tumors with precision. 🔹 13 top cancer centers on board. 🔹 Phase III trial nears completion. 🔹 Analysts call it undervalued. Big milestones ahead! https://www.tipranks.com/news/the-fly/meet-renovorx-fly-exclusive-interview-with-ceo-shaun-bagai-thefly
0 · Reply
jcooptechit
jcooptechit Aug. 7 at 5:41 AM
Current Focus List: 🧐 - CAN - PROP - IPA - KODK - $RNTX - $WINT - $AIMD - $BINI ~ Traders Hub
0 · Reply
Majid74
Majid74 Aug. 2 at 12:01 PM
$RNTX https://ir.reintx.com/news-releases/news-release-details/rein-therapeutics-enters-agreements-21-million-flexible
0 · Reply
Majid74
Majid74 Aug. 2 at 9:14 AM
$RNTX News??
0 · Reply
Aburose
Aburose Aug. 1 at 10:35 PM
$RNTX next week target between 12-15
2 · Reply
Aburose
Aburose Aug. 1 at 10:23 PM
$RNTX Rein Therapeutics Enters Into Two Strategic Financing Agreements With Affiliate Of Yorkville Advisors Global, Providing Potential For Access To Up To $21M In Capital
0 · Reply
dbr_island
dbr_island Aug. 1 at 10:17 PM
There goes $RNTX VCIG is my next one Here’s why👇
0 · Reply
jcooptechit
jcooptechit Jul. 31 at 2:08 PM
Revolutionary Biotech Targeting Pancreatic Cancer. $RNTX has a 700%+ Upside Potential! 🔸FDA-cleared RenovoCath delivers 100x tumor exposure with less toxicity. 🔸TIGeR-PaC shows data of a 6-month survival boost and in Phase III. 🔸Analysts are bullish, projecting price targets up to $12. 🔸Backed by a solid $7.1M cash runway, no dilution risk, and insider buying. Communicated - Disclaimer https://stockresearchtoday.com/delivering-therapy-where-it-matters/
0 · Reply
Tunes444
Tunes444 Jul. 30 at 1:42 PM
$RNTX my thoughts exactly.
0 · Reply
DarcyF
DarcyF Jul. 30 at 1:24 PM
0 · Reply
MagelaMason
MagelaMason Jul. 30 at 1:23 PM
$RNTX Financing is for sure going to keep the lights on for next little while. Hopefully they can get some good results and keep the momentum going forward.
0 · Reply